Welcome to our dedicated page for 3M news (Ticker: MMM), a resource for investors and traders seeking the latest updates and insights on 3M stock.
3M Company (NYSE: MMM) generates a steady flow of news that reflects its role as a science-driven manufacturing conglomerate. Investors and observers following MMM news will find updates on financial performance, investor events, product and technology announcements, and education and community initiatives. The company regularly issues press releases describing how it applies science to transform industries with customer-focused solutions built on diverse technology platforms and a global footprint.
News about 3M often includes earnings reports and guidance updates, where the company discusses sales, margins, earnings per share, and cash flow, and files related Form 8-K reports. These releases can provide insight into how 3M’s Safety and Industrial, Transportation and Electronics, and Consumer segments are performing and how portfolio actions, such as the spin-off of its healthcare business into Solventum, affect its results.
Another key category of MMM news covers technology and digital innovation. Recent announcements highlight tools such as Ask 3M, an AI-powered assistant that helps customers navigate 3M’s adhesives and tapes, and the 3M Digital Materials Hub, which supports virtual materials sampling and collaboration with 3M scientists. The company also showcases its materials and solutions for consumer electronics, automotive, advanced manufacturing, and data centers at events like CES.
3M news also features consumer brand campaigns and education programs, such as Scotch Brand initiatives around holiday gifting and the 3M Young Scientist Challenge, which recognizes middle school innovators. By reviewing this news stream, readers can see how 3M combines financial reporting, product and technology updates, and science education efforts. Bookmarking the MMM news page on Stock Titan allows users to quickly access these diverse updates in one place.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
On April 27, 2023, 3M Health Care announced that its 3M™ Veraflo™ Therapy received the first FDA clearance for hydromechanical removal of infectious materials, reducing the need for surgical debridements. This innovative therapy promotes healing by creating an optimal environment for granulation tissue formation.
The FDA clearance is an important milestone, enabling clinicians to provide more effective wound care while potentially reducing healthcare costs. According to 3M, approximately 40% of wounds become infected, which complicates healing and increases costs for health systems. Veraflo Therapy is designed to lower surgical intervention rates and expedite patient recovery.
With the increasing complexity of wound care due to rising patient comorbidities, Veraflo Therapy is positioned as a solution that may improve both patient outcomes and cost efficiency.
3M (NYSE: MMM) reported Q1 2023 results showing GAAP earnings per share of $1.76, down from $2.26 in Q1 2022, and adjusted earnings per share of $1.97, compared to $2.63 the previous year. Total sales fell 9.0% year-on-year to $8.0 billion, with an organic decline of 4.9%. Operating cash flow increased by 26% to $1.3 billion. The company announced a restructuring plan affecting 6,000 positions, expected to yield annual pre-tax savings of $700 million to $900 million. Full-year 2023 guidance remains at adjusted earnings per share of $8.50 to $9.00, with projected adjusted total sales growth of -6% to -2%.
3M has announced significant changes in its senior management team as part of its strategy to enhance profitability and growth. Effective immediately, Michael Vale has been appointed Group President and Chief Business and Country Officer, overseeing three major business groups: Safety and Industrial, Transportation and Electronics, and Consumer. Other key appointments include Karina Chavez and Chris Goralski as Group Presidents for Consumer and Safety and Industrial Businesses, respectively. The company is also expanding the roles of Monish Patolawala and John Banovetz in finance and technology. The announcement comes with forward-looking statements highlighting potential risks including economic conditions, regulatory challenges, and ongoing legal matters concerning the company’s PFAS products.